{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:26:45Z","timestamp":1748003205213},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.diabres.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T18:43:15Z","timestamp":1469817795000},"page":"75-82","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population"],"prefix":"10.1016","volume":"119","author":[{"given":"Fumiaki","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tsukiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eigoro","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruaki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyoshi","family":"Sada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diabres.2016.07.005_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/obr.12229","article-title":"Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies","volume":"16","author":"O\u2019Neill","year":"2015","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11906-010-0164-9","article-title":"Metabolic syndrome: from the genetics to the pathophysiology","volume":"13","author":"Sookoian","year":"2011","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"10.1016\/j.diabres.2016.07.005_b0015","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/diacare.25.10.1790","article-title":"Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam","volume":"25","author":"Klein","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2016.07.005_b0020","first-page":"797","article-title":"Management issues in the metabolic syndrome","volume":"54","author":"Deedwania","year":"2006","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"10.1016\/j.diabres.2016.07.005_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bl\u00fcher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2016.07.005_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1650524","article-title":"Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men \u2013 role of the metabolic syndrome","volume":"76","author":"Cigolini","year":"1996","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.diabres.2016.07.005_b0035","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2016.07.005_b0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1995","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.diabres.2016.07.005_b0045","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"Sepp\u00e4l\u00e4-Lindroos","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.diabres.2016.07.005_b0050","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/oby.2002.118","article-title":"Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes","volume":"10","author":"Tiikkainen","year":"2002","journal-title":"Obes Res"},{"issue":"15","key":"10.1016\/j.diabres.2016.07.005_b0055","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"issue":"36","key":"10.1016\/j.diabres.2016.07.005_b0060","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0065","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.orcp.2010.12.007","article-title":"Intrahepatic lipid content is linked to insulin resistance in obese subjects","volume":"5","author":"Sada","year":"2011","journal-title":"Obes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.diabres.2016.07.005_b0075","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.diabres.2016.07.005_b0080","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMc1412427","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Stefan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2016.07.005_b0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nm.3116","article-title":"Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans","volume":"19","author":"Stefan","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.diabres.2016.07.005_b0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0095","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"48","key":"10.1016\/j.diabres.2016.07.005_b0100","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0608537103","article-title":"Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men","volume":"103","author":"Petersen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.diabres.2016.07.005_b0105","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.diabres.2016.07.005_b0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2014.08.041","article-title":"Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy","volume":"62","author":"Wong","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2016.07.005_b0115","first-page":"1509","article-title":"The history of the diagnostic criteria for alcoholic liver disease and current status of alcoholic liver disease in Japan","volume":"109","author":"Tsutsutmi","year":"2012","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"issue":"6","key":"10.1016\/j.diabres.2016.07.005_b0120","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","article-title":"Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary","volume":"22","author":"Farrell","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.diabres.2016.07.005_b0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"16","key":"10.1016\/j.diabres.2016.07.005_b0130","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diabres.2016.07.005_b0135","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.orcp.2011.09.001","article-title":"Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus","volume":"6","author":"Sato","year":"2012","journal-title":"Obes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2016.07.005_b0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.diabres.2015.04.008","article-title":"Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes","volume":"109","author":"Kato","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2016.07.005_b0145","doi-asserted-by":"crossref","first-page":"e92170","DOI":"10.1371\/journal.pone.0092170","article-title":"Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease","volume":"9","author":"Kato","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.diabres.2016.07.005_b0150","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","article-title":"Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy","volume":"110","author":"Wei","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.diabres.2016.07.005_b0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-2275(20)42968-2","article-title":"Glycolipids and other lipid constituents of normal human liver","volume":"11","author":"Kwiterovich","year":"1970","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0160","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.orcp.2009.10.001","article-title":"Evaluation of whole-abdominal fat volume by 700-slice CT scanning and comparison with the umbilical fat area anthropometric indices","volume":"4","author":"Furukawa","year":"2010","journal-title":"Obes Res Clin Pract"},{"issue":"15","key":"10.1016\/j.diabres.2016.07.005_b0165","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.diabres.2016.07.005_b0170","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ijo.2010.216","article-title":"Characterizing the profile of obese patients who are metabolically healthy","volume":"35","author":"Primeau","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.diabres.2016.07.005_b0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1467-789X.2012.01033.x","article-title":"Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome","volume":"13","author":"M\u00fcller","year":"2012","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI78425","article-title":"Metabolically normal obese people are protected from adverse effects following weight gain","volume":"125","author":"Fabbrini","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.diabres.2016.07.005_b0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2010.01.008","article-title":"Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations","volume":"52","author":"Lee","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.12120896","article-title":"Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis","volume":"267","author":"Tang","year":"2013","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.diabres.2016.07.005_b0195","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.14140754","article-title":"Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease","volume":"274","author":"Tang","year":"2015","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.diabres.2016.07.005_b0200","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.diabres.2016.07.005_b0205","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/ajg.2009.361","article-title":"Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population","volume":"104","author":"Gunji","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.diabres.2016.07.005_b0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hep.27036","article-title":"Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice","volume":"60","author":"Kwon","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.diabres.2016.07.005_b0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00208273","article-title":"Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population","volume":"94","author":"Takeshita","year":"1994","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.diabres.2016.07.005_b0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1572-0241.2003.04013.x","article-title":"Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related","volume":"99","author":"Hayashi","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.diabres.2016.07.005_b0225","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/nbm.1622","article-title":"In vivo characterization of the liver fat 1H MR spectrum","volume":"24","author":"Hamilton","year":"2011","journal-title":"NMR Biomed"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716302510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716302510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T06:31:40Z","timestamp":1656916300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822716302510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"alternative-id":["S0168822716302510"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.07.005","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}